Agios Pharmaceuticals AGIO Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's free cash flow?
- Agios Pharmaceuticals (AGIO) reported free cash flow of -$119.69M in Q1 2026.
- How has Agios Pharmaceuticals's free cash flow changed year-over-year?
- Agios Pharmaceuticals's free cash flow decreased by 6.6% year-over-year, from -$112.26M to -$119.69M.
- What is the long-term trend for Agios Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Agios Pharmaceuticals's free cash flow has grown at a -2.2% compound annual growth rate (CAGR), from -$413.06M to -$377.29M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.